Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients

David Low; Jennifer Xu; Prashant Tibrewal; Tarun Bastiampillai; Rohanjeet Dhillon

doi:10.1177/0004867416656806

Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients

David Low, Jennifer Xu, Prashant Tibrewal, Tarun Bastiampillai, Rohanjeet Dhillon

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	198-198
Number of pages	1
Journal	Australian and New Zealand Journal of Psychiatry
Volume	51
Issue number	2
DOIs	https://doi.org/10.1177/0004867416656806
Publication status	Published - 1 Feb 2017

Keywords

Catatonia
lorazepam
Correspondence

Access to Document

10.1177/0004867416656806Licence: In Copyright

Cite this

@article{76ad7adb7f224dc484c225e59788104e,

title = "Parenteral lorazepam{\textquoteright}s unavailability in Australia and the impact for catatonic patients",

keywords = "Catatonia, lorazepam, Correspondence",

author = "David Low and Jennifer Xu and Prashant Tibrewal and Tarun Bastiampillai and Rohanjeet Dhillon",

year = "2017",

month = feb,

day = "1",

doi = "10.1177/0004867416656806",

language = "English",

volume = "51",

pages = "198--198",

journal = "Australian and New Zealand Journal of Psychiatry",

issn = "0004-8674",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients

AU - Low, David

AU - Xu, Jennifer

AU - Tibrewal, Prashant

AU - Bastiampillai, Tarun

AU - Dhillon, Rohanjeet

PY - 2017/2/1

Y1 - 2017/2/1

KW - Catatonia

KW - lorazepam

KW - Correspondence

UR - http://www.scopus.com/inward/record.url?scp=85012054746&partnerID=8YFLogxK

U2 - 10.1177/0004867416656806

DO - 10.1177/0004867416656806

M3 - Letter

SN - 0004-8674

VL - 51

SP - 198

EP - 198

JO - Australian and New Zealand Journal of Psychiatry

JF - Australian and New Zealand Journal of Psychiatry

IS - 2

ER -

Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients

Keywords

Access to Document

Other files and links

Cite this